Variant report

Variant	nsv900733
Chromosome Location	chr13:86192376-86309366
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:5)
LncRNA
region (count:8)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:5 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr13:86226206..86227148-chr9:80190237..80190893,2	MCF-7	breast:
2	chr13:86281640..86283292-chr13:86288920..86291298,2	MCF-7	breast:
3	chr13:86279490..86281664-chr13:86283799..86286531,3	MCF-7	breast:
4	chr13:86281640..86283292-chr13:86288920..86291298,2	MCF-7	breast:
5	chr13:86279490..86281664-chr13:86283799..86286531,3	MCF-7	breast:

(count:8 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-SLITRK6-1	chr13:86215835-86215991	XLOC_010681
2	lnc-SLITRK6-1	chr13:86205771-86205977	XLOC_010681
3	lnc-SLITRK5-30	chr13:86250665-86250748	NONHSAT034569
4	lnc-SLITRK6-1	chr13:86205874-86205977	XLOC_010681
5	lnc-SLITRK5-30	chr13:86240824-86240895	NONHSAT034569
6	lnc-SLITRK6-1	chr13:86203729-86203774	XLOC_010681
7	lnc-SLITRK5-30	chr13:86270269-86270344	NONHSAT034569
8	lnc-SLITRK6-1	chr13:86215835-86216180	XLOC_010681

No data

Variant related genes	Relation type
CELSR3	miRNA target sites

Extended variants
information (count: 3948 )
Associated
traits (count: 92 )

Variant overlapped rSNPs/rCNVs (count:3948 , 50 per page) page: 1 2 3 4 5 6 7 ... 79

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs1928129	chr13:86192376-86192377	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs567010439	chr13:86192377-86192378	Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs534511177	chr13:86192396-86192397	Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs533241512	chr13:86192612-86192613	Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs76429462	chr13:86192635-86192636	Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs370030501	chr13:86192660-86192661	Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs568559102	chr13:86192667-86192668	Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs554566581	chr13:86192701-86192702	Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs9602783	chr13:86192704-86192705	Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs2225232	chr13:86192712-86192713	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs143409568	chr13:86192781-86192782	Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs532168544	chr13:86192802-86192803	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs7324429	chr13:86192805-86192806	Bivalent Enhancer Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
14	rs562793705	chr13:86192877-86192878	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs530218213	chr13:86192893-86192894	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs548252352	chr13:86192935-86192936	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs112666851	chr13:86192952-86192953	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs190419712	chr13:86192953-86192954	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs548630291	chr13:86192963-86192964	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs566849986	chr13:86192980-86192981	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs552887127	chr13:86192990-86192991	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs371010936	chr13:86192991-86192992	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs560415547	chr13:86193400-86193401	Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs540120363	chr13:86193447-86193448	Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs527676384	chr13:86193493-86193494	Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs552609463	chr13:86193520-86193521	Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs564730259	chr13:86193529-86193530	Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs73542494	chr13:86193533-86193534	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
29	rs2094606	chr13:86193597-86193598	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
30	rs568620589	chr13:86193599-86193600	Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs535706896	chr13:86193608-86193609	Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs368544177	chr13:86193623-86193624	Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs115118446	chr13:86193648-86193649	Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs142942134	chr13:86193666-86193667	Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs533496212	chr13:86193674-86193675	Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs544032175	chr13:86193717-86193718	Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs185751424	chr13:86193766-86193767	Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs558137956	chr13:86193780-86193781	Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs78793799	chr13:86193785-86193786	Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs189676074	chr13:86193800-86193801	Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs554161437	chr13:86201622-86201623	Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs4540964	chr13:86201628-86201629	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
43	rs189191004	chr13:86201656-86201657	Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs558615635	chr13:86201671-86201672	Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs191729086	chr13:86201707-86201708	Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs544123747	chr13:86201729-86201730	Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs67723051	chr13:86202009-86202010	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs533246146	chr13:86202013-86202014	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs377720497	chr13:86202078-86202079	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs180911615	chr13:86202083-86202084	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:92)

Disease	PMID	Source
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
HIV/AIDS	22032296	CNVD
Prostate cancer	16705090	CNVD
High-proliferative meningiomas	17937814	CNVD
Cancer	20164919	CNVD
Autism	22495311	CNVD
Chordoma	21602918	CNVD
Bladder cancer	21949216	CNVD
Acute myeloid leukemia	16864856	CNVD
Burkitt''s lymphoma	18698080	CNVD
Cancer	21637783	CNVD
Medulloblastoma	21979893	CNVD
Chronic lymphocytic leukemia	21518781	CNVD
colon cancer	17210682	CNVD
Endometrial cancer	22040021	CNVD
Colorectal cancer	20709793	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Ovarian cancer	20844748	CNVD
Colorectal cancer	19359472	CNVD
Intracranial aneurysm	19064780	CNVD
Breast cancer	19287154	CNVD
Acute myeloid leukemia	18379011	CNVD
Human rectal carcinomas	16397240	CNVD
Olfactory neuroblastoma	18408657	CNVD
Multiple myeloma	17077331	CNVD
Ependymoma	16718352	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Colorectal cancer	16272173	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	17133270	CNVD
Myoepithelioma	18604193	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Prostate cancer	18632612	CNVD
Colorectal cancer	21586687	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Developmental delay	21147756	CNVD
Melanoma	18172304	CNVD
Prostate cancer	16573809	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Basal cell lymphoma	17053054	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Breast cancer	21858162	CNVD
Metanephric adenoma	20802469	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Gastric cancer	17908304	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Liposarcoma	21253554	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Acute myeloid leukemia	20729466	CNVD
abnormal development	18461090	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Congenital anomalies of the kidney and urinary tract	18316590	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Esophageal cancer	21851588	CNVD
Prostate cancer	21965145	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma multiforme	22286061	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Urothelial cell carcinoma	18451213	CNVD
Developmental delay	19490664	CNVD
Neurodevelopmental disorder	22521361	CNVD
Cancer	21220470	CNVD
Cancer	21183584	CNVD
Omodysplasia	19481194	CNVD
Breast cancer	22032731	CNVD
Congenital anomalies of the kidney and urinary tract	20467480	CNVD
Cancer	17160897	CNVD
Mantle cell lymphoma	19690137	CNVD
Rhabdomyosarcoma	17210683	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Schizophrenia	23813976	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:200 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr13:86191600-86192400	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
2	chr13:86192600-86193000	Enhancers	Primary hematopoietic stem cells short term culture	blood
3	chr13:86192600-86193000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
4	chr13:86192600-86193000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
5	chr13:86192800-86193000	Bivalent Enhancer	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
6	chr13:86193400-86193800	Enhancers	iPS-15b Cell Line	embryonic stem cell
7	chr13:86193400-86193800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
8	chr13:86201600-86201800	Enhancers	Brain Anterior Caudate	brain
9	chr13:86202000-86204200	Weak transcription	Brain Anterior Caudate	brain
10	chr13:86203600-86204000	Enhancers	HUES48 Cell Line	embryonic stem cell
11	chr13:86203600-86204000	Enhancers	HUES64 Cell Line	embryonic stem cell
12	chr13:86203600-86204200	Enhancers	iPS-18 Cell Line	embryonic stem cell
13	chr13:86203600-86204200	Enhancers	Rectal Smooth Muscle	rectum
14	chr13:86204200-86205000	Enhancers	Brain Anterior Caudate	brain
15	chr13:86204200-86206800	Weak transcription	Rectal Smooth Muscle	rectum
16	chr13:86204800-86205000	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
17	chr13:86204800-86205000	Enhancers	Brain Substantia Nigra	brain
18	chr13:86205000-86206000	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
19	chr13:86205000-86206000	Weak transcription	Brain Anterior Caudate	brain
20	chr13:86206000-86207800	Enhancers	Brain Anterior Caudate	brain
21	chr13:86206000-86208000	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
22	chr13:86206400-86207000	Enhancers	Fetal Lung	lung
23	chr13:86206600-86207400	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
24	chr13:86206600-86207800	Enhancers	Brain Substantia Nigra	brain
25	chr13:86206800-86207400	Enhancers	Rectal Smooth Muscle	rectum
26	chr13:86212400-86212600	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
27	chr13:86212400-86212600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
28	chr13:86212400-86212600	Enhancers	Adipose Nuclei	Adipose
29	chr13:86212600-86212800	Flanking Active TSS	Adipose Nuclei	Adipose
30	chr13:86212600-86213000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
31	chr13:86212800-86213000	Enhancers	Adipose Nuclei	Adipose
32	chr13:86213000-86213200	Flanking Active TSS	Adipose Nuclei	Adipose
33	chr13:86213000-86214000	Genic enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
34	chr13:86213200-86213400	Enhancers	Adipose Nuclei	Adipose
35	chr13:86213600-86213800	Bivalent Enhancer	Fetal Muscle Trunk	muscle
36	chr13:86214000-86215000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
37	chr13:86214400-86225000	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
38	chr13:86218000-86218400	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
39	chr13:86218400-86220200	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
40	chr13:86219000-86219400	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
41	chr13:86220200-86220600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
42	chr13:86223800-86224000	Enhancers	HMEC	breast
43	chr13:86224000-86225000	Weak transcription	HMEC	breast
44	chr13:86224400-86228200	Enhancers	Placenta Amnion	Placenta Amnion
45	chr13:86225000-86225400	Enhancers	Esophagus	oesophagus
46	chr13:86225000-86225600	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
47	chr13:86225000-86225800	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
48	chr13:86225000-86226000	Enhancers	HMEC	breast
49	chr13:86225000-86226000	Enhancers	NHEK	skin
50	chr13:86225000-86226200	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links